Amyloid
peptides nucleate from monomers to aggregate into fibrils
through primary nucleation. Pre-existing fibrils can then act as seeds
for additional monomers to fibrillize through secondary nucleation.
Both nucleation processes occur simultaneously, yielding a distribution
of fibril polymorphs that can generate a spectrum of neurodegenerative
effects. Understanding the mechanisms driving polymorph structural
distribution during both nucleation processes is important for uncovering
fibril structure–function relationships, as well as for creating
polymorph distributions in vitro that better match fibril structures
found in vivo. Here, we explore how cross-seeding wild-type (WT) Aβ1–40 with Aβ1–40 mutants E22G
(Arctic) and E22Δ (Osaka), as well as with WT Aβ1–42, affects the distribution of fibril structural polymorphs and how
changes in structural distribution impact toxicity. Transmission electron
microscopy analysis revealed that fibril seeds derived from mutants
of Aβ1–40 imparted their structure to WT Aβ1–40 monomers during secondary nucleation, but WT Aβ1–40 fibril seeds do not affect the structure of fibrils
assembled from mutant Aβ1–40 monomers, despite
the kinetic data indicating accelerated aggregation when cross-seeding
of any combination of mutants. Additionally, WT Aβ1–40 fibrils seeded with mutant fibrils produced similar structural distributions
to the mutant seeds with similar cytotoxicity profiles. This indicates
that mutant fibril seeds not only impart their structure to growing
WT Aβ1–40 aggregates but also impart cytotoxic
properties. Our findings establish a relationship between the fibril
structure and the phenotype on a polymorph population level and that
these properties can be passed on through secondary nucleation to
the succeeding generations of fibrils.